Skip Navigation


NDT Advance Access originally published online on September 23, 2006
Nephrology Dialysis Transplantation 2006 21(12):3377-3388; doi:10.1093/ndt/gfl543
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/12/3377    most recent
gfl543v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Morais, C.
Right arrow Articles by Healy, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morais, C.
Right arrow Articles by Healy, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines

Christudas Morais1,2, Betty Pat3, Glenda Gobe3, David W. Johnson4 and Helen Healy1,2

1Conjoint Renal Laboratory, Bancroft Centre, Queensland Health Pathology Service, Royal Brisbane and Women's Hospital, 300 Herston Road, Brisbane, Queensland 4006, 2Department of Renal Medicine, Royal Brisbane and Women's Hospital, Herston, 3Discipline of Molecular and Cellular Pathology, School of Medicine, University of Queensland, Brisbane, Queensland 4029 and 4Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia

Correspondence and offprint requests to: Dr Helen Healy, MBBS, PhD, FRACP, Director of Renal Medicine, Royal Brisbane and Women's Hospital, Herston, Brisbane, Queensland, 4029, Australia. Email: Helen_Healy{at}health.qld.gov.au

Background. The activation of nuclear factor-{kappa}B (NF-{kappa}B) has been implicated in the development, progression and metastasis of renal cell carcinoma (RCC). This study investigates the effect of pyrrolidine dithiocarbamate (PDTC), a NF-{kappa}B inhibitor, on two metastatic human RCC cell lines, ACHN and SN12K1.

Methods. RCC cell lines and normal cells were exposed to 25 or 50 µM of PDTC. Apoptosis was measured by flow cytometry and TdT-mediated nick end labelling methods. Cell viability and proliferation were measured by MTT and BrdU assays, respectively. Expression of NF-{kappa}B subunits, I{kappa}Bs, I{kappa}B Kinase (IKK) complex and apoptotic regulatory proteins were analysed by western blotting and/or immunofluorescence. DNA-binding activity of NF-{kappa}B subunits were measured by ELISA.

Results. RCC cell lines had a higher basal level expression of all the five subunits of NF-{kappa}B than normal primary cultures of human proximal tubular epithelial cells or HK-2 cells. PDTC decreased the viability and proliferation of RCC, but not normal cells. Of the two RCC cell lines, ACHN had a higher basal level expression of all the five NF-{kappa}B subunits than SN12K1 and was more resistant to PDTC. While PDTC induced an overall decrease in expression of all the five NF-{kappa}B subunits in both RCC cell lines, unexpectedly, it increased the nuclear expression of NF-{kappa}B in ACHN, but not in SN12K1. PDTC reduced the DNA-binding activity of all the NF-{kappa}B subunits and the expression of the IKK complex (IKK-{alpha}, IKK-ß and IKK-{gamma}) and the inhibitory units I{kappa}B-{alpha} and I{kappa}B-ß. PDTC induced a significant increase in apoptosis in both RCC cell lines. This was associated with a decrease in expression of the anti-apoptotic proteins, Bcl-2 and Bcl-XL, without marked changes in the pro-apoptotic protein Bax.

Conclusion. These data suggest that PDTC has the potential to be an anticancer agent in some forms of RCC.

Keywords: apoptosis; IKK complex; NF-{kappa}B; renal cell carcinoma


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J AndrolHome page
Y. O. Ilbey, E. Ozbek, A. Simsek, M. Cekmen, A. Otunctemur, and A. Somay
Chemoprotective Effect of a Nuclear Factor-{kappa}B Inhibitor, Pyrrolidine Dithiocarbamate, Against Cisplatin-Induced Testicular Damage in Rats
J Androl, September 1, 2009; 30(5): 505 - 514.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.